|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
53189031
線上人數 :
1139
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"ting l l"的相關文件
顯示項目 1-10 / 96 (共10頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-05-05T09:10:38Z |
Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35
|
WEI-CHU CHIE; Hong R.-L.; Lai C.-C.; Ting L.-L.; Hsu M.-M. |
| 臺大學術典藏 |
2022-05-05T08:48:57Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L.; Ting L.-L.; Ko J.-Y.; Hsu M.-M.; Sheen T.-S.; Lou P.-J.; CHIA-CHUN WANG; Chung N.-N.; Lui L.T. |
| 臺大學術典藏 |
2022-05-05T08:48:57Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L.; Sheen T.S.; Ko J.Y.; Hsu M.M.; CHIA-CHUN WANG; Ting L.L. |
| 臺大學術典藏 |
2022-04-21T06:51:36Z |
Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma
|
Yen R.-F.; Chen, Tony Hsiu Hsi; Ting L.-L.; Tzen K.-Y.; Pan M.-H.; Hong R.-L. |
| 臺大學術典藏 |
2022-03-04T06:53:46Z |
Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma
|
Ko J.-Y.; Wang C.-P.; Ting L.-L.; Yang T.-L.; CHING-TING TAN |
| 臺大學術典藏 |
2021-11-18T04:58:21Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L; Sheen T.S; JENG-YUH KO; Hsu M.M; Wang C.C; Ting L.L. |
| 臺大學術典藏 |
2021-11-18T04:58:20Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M; Chiou C.-R; JENG-YUH KO; Sheen T.-S; Hong R.-L; Ting L.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; Ting L.-L; JENG-YUH KO; Hsu M.-M; Sheen T.-S; Lou P.-J; Wang C.-C; Chung N.-N; Lui L.T. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M; Hong R.-L; Ting L.-L; JENG-YUH KO; Sheen T.-S; Lou P.-J. |
| 臺大學術典藏 |
2021-11-18T04:58:17Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; Lin C.-Y; Ting L.-L; JENG-YUH KO; Hsu M.-M. |
顯示項目 1-10 / 96 (共10頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
